Groundbreaking Melanoma Therapies Featured at ASCO’s Annual Meeting Promising results from two separate melanoma treatment studies stole the spotlight at the recent A...

In their most honest moments, the best and brightest scientific researchers agree that competition is good.  When researchers have to apply for limited funds they shar...

WASHINGTON—Unless you are Cindy Crawford, you might give little thought to the moles, freckles and other marks dotting your skin.  But, as an estimated 68,000 pe...

Today’s melanoma symposium in Seattle featured a panel of patients telling their stories.    Some have been fighting melanoma for years.  One was ...

In some ways cancer patients are just people.  Some are mean, some are nice.  Some are caring, some are indifferent.  Having said that, cancer, like most maj...

That is the headline in an article by Dr. John Briffa, a UK physician.  Citing a 2008 article in the British Medical Journal, the author claims that melanoma incidence...

I won’t give her name here, but her story is worth telling.  She was a young woman when she found an odd mole on her back.  Simple surgery, but the path rep...

To say that a patient failed a treatment is to use fairly common jargon in describing a situation in which the patient is no longer benefitting from that treatment.  T...

About 2/3 of melanomas are caused by exposure to UV radiation.  Often the damage is done in the days of our youth, and only manifested later in life.  So if peopl...

WASHINGTON, D.C.— Most melanoma patients never hear about the most cutting edge treatments available to them.  That’s because some of the most innovative a...

The MRF is committed to funding research for finding new treatments that will make a meaningful impact on survival for melanoma patients and understanding ways to improve p...

There’s been much buzz about the new Showtime series, “The Big C” and the portrayal of cancer on the show.  But what do melanoma patients think about...